Mosaburo Kainuma, Shinji Ouma, Shinobu Kawakatsu, Osamu Iritani, Ken-Ichiro Yamashita, Tomoyuki Ohara, . . . Yoshio Tsuboi. (2022). An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease. Frontiers Media S.A..
Chicago Style (17th ed.) CitationMosaburo Kainuma, et al. An Exploratory, Open-label, Randomized, Multicenter Trial of Hachimijiogan for Mild Alzheimer's Disease. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationMosaburo Kainuma, et al. An Exploratory, Open-label, Randomized, Multicenter Trial of Hachimijiogan for Mild Alzheimer's Disease. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.